These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30853445)

  • 1. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies.
    Zhou R; Fan X; Schnabl B
    Transl Res; 2019 Jul; 209():22-38. PubMed ID: 30853445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
    Betrapally NS; Gillevet PM; Bajaj JS
    Gastroenterology; 2016 Jun; 150(8):1745-1755.e3. PubMed ID: 26948887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
    Lee NY; Suk KT
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
    Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
    Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and the liver.
    Federico A; Dallio M; Caprio GG; Ormando VM; Loguercio C
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):385-398. PubMed ID: 28927250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
    Kawaratani H; Moriya K; Namisaki T; Uejima M; Kitade M; Takeda K; Okura Y; Kaji K; Takaya H; Nishimura N; Sato S; Sawada Y; Seki K; Kubo T; Mitoro A; Yamao J; Yoshiji H
    Int J Mol Med; 2017 Aug; 40(2):263-270. PubMed ID: 28627645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.
    Macnaughtan J; Jalan R
    Am J Gastroenterol; 2015 Oct; 110(10):1399-410; quiz 1411. PubMed ID: 26416191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2018 Feb; 22(1):121-132. PubMed ID: 29128052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure.
    Kim SE; Park JW; Kim HS; Jang MK; Suk KT; Kim DJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.
    Lachar J; Bajaj JS
    Semin Liver Dis; 2016 Sep; 36(4):327-330. PubMed ID: 27997972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
    Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
    Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-Microbiome Axis in Health and Disease.
    Adolph TE; Grander C; Moschen AR; Tilg H
    Trends Immunol; 2018 Sep; 39(9):712-723. PubMed ID: 29843959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.